Calendar TC Biopharm (Holdings) Plc

Equities

TCBP

US87807D4007

End-of-day quote Nasdaq 06:00:00 2024-04-23 pm EDT 5-day change 1st Jan Change
1.47 USD -6.96% Intraday chart for TC Biopharm (Holdings) Plc +8.89% -53.63%

Chart calendar TC Biopharm (Holdings) Plc

9c7f07cb03aadb3.TnaoE2rGZS6D8w-zM4QYSa4tqBs23YcfdjAkaSvoBzQ.OELFfgmlEkDKrEjLS-dZK8JonGx6vLAyEANhWGOMYFIBDJlHD5Q_f8qreA~808718823f55069017c271b6d308012e

Upcoming events on TC Biopharm (Holdings) Plc

No events available

Past events on TC Biopharm (Holdings) Plc

2024-03-05 04:30 pm Business Update Call
2024-02-26 CAR-TCR Summit
2024-01-24 01:30 pm Sequire Investor Summit
2023-10-04 01:00 pm LD Micro Main Conference
2023-09-11 07:00 am H.C. Wainwright Global Investment Conference
2023-06-07 05:00 pm LD Micro Invitational Conference
2023-04-26 11:00 am Sequire Investor Summit
2023-02-21 12:00 pm Business Update Call
2022-12-12 09:00 am Interim 2022 Earnings Release
2022-10-26 11:30 am LD Micro Main Event Conference
2022-10-12 08:00 am Dawson James Small Cap Growth Conference
2022-09-13 04:30 pm H.C. Wainwright Global Investment Conference
2022-07-28 02:30 pm Gamma Delta T Therapies Summit
2022-07-28 12:00 pm Gamma Delta T Therapies Summit - Defining a 'Super-Donor' & Discussing Cell Source Considerations
2022-07-28 12:00 pm Gamma Delta T Therapies Summit - Sharing Perspectives on the Application & Attractiveness of Gamma D
2022-07-27 04:30 pm Gamma Delta T Therapies Summit
2022-07-26 11:00 am Gamma Delta T Therapies Summit
2022-07-13 03:30 am Innovating Cell and Gene Therapy Quality Control Conference
2022-06-28 Onco Cell Therapy Summit
2022-06-14 05:15 pm Next Generation CAR & T Cell Therapies Conference

Annual results

Fiscal PeriodDecember 2020 2021 2022
Net sales
Million USD
Released
Forecast
Spread
2,73


2,42
3,93
-38.35%
4,80
2,47
94.28%
EBITDA
Released
Forecast
Spread
0,00


0,00
0,00
-
0,00
0,00
-
EBIT
Million USD
Released
Forecast
Spread
0,00


0,00
0,00
-
-15,0
-22,8
33.94%
Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
0,00


-18,3
-18,7
2.07%
-3,89
-13,1
70.42%
Net income
Million USD
Released
Forecast
Spread
-7,54


-16,6
-17,7
6.01%
-1,74
-12,2
85.81%
EPS
USD
Released
Forecast
Spread
0,00


-856
-877
2.34%
-50,5
-300
83.15%
Announcement Date26/07/2113/05/2201/05/23

Quarterly results

Fiscal PeriodDecember 2022 Q2 2022 S1 2022 Q3 2022 Q4 2023 Q2
Net sales
Million USD
Released
Forecast
Spread







0,61


0,62

0,00
0,62
-
EBIT
Million USD
Released
Forecast
Spread







-6,19


-6,63




Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread







-6,19


-6,63




Net income
Million USD
Released
Forecast
Spread



0,63



-6,19


-6,63




EPS
USD
Released
Forecast
Spread

-110

18,6



-130


-139




Announcement Date-12/12/22--08/11/23

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. TCBP Stock
  4. Calendar TC Biopharm (Holdings) Plc